• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MDABY:US

14.0500 USD 0.3900 2.86%

As of 20:10:00 ET on 09/30/2014.

Snapshot for Meda AB (MDABY)

Open: 13.8950 Day's Range: 13.8950 - 14.0500 Volume: 256
Previous Close: 13.6600 52wk Range: 10.4900 - 21.5000 1-Yr Rtn: +23.23%

Stock Chart for MDABY

No chart data available.
  • MDABY:US 14.0500
  • 1D
  • 1M
  • 1Y
13.6600
Interactive MDABY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MDABY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 4,246.52
Shares Outstanding (M) 302.24
30 Day Average Volume 1,029
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.71%
Cash Dividend (USD) 0.2801
Dividend Ex-Date 05/08/2014
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MDABY

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MDABY

Meda AB is a specialty pharmaceutical company. The Company imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. Meda's products are sold in the Nordic countries and in the Baltic states on behalf of foreign manufacturers. The Company markets to wholesale dealers and hospitals.

Henrik StenqvistExec VP/CFOMaria CarellExec VP:North America
Dirk GroenExec VP:Marketing OTCErik HaefflerExec VP:Manufacturing
More Company Profile & Key Executives for MDABY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil